Close
CDMO Safety Testing 2026
Novotech

MHRA approves Ajanta Pharma Paithan manufacturing plant

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Daewoong and Chime Biologics Partner for Biosimilar Push

Chime Biologics and Daewoong Pharmaceutical have entered into a...

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has...

Aragen Achieves Daretabart Commercial-scale GMP Production

Aragen, a global leader in Contract Research, Development, and...
- Advertisement -

The Medicines & Healthcare products Regulatory Agency (MHRA) of UK has approved India-based Ajanta Pharma’s formulation manufacturing plant at Paithan, Aurangabad, India. Ajanta’s Paithan manufacturing plant has also got the US Food and Drug Administration (FDA) approval earlier.Additionally, Ajanta’s Paithan facility also holds the WHO Pre-qualification approval from WHO Geneva.Ajanta Pharma managing director Yogesh Agrawal said they continue to build expertise in the quality standards and approvals from the most stringent regulatory authorities like US, UK and WHO Pre-qualification are testimony to their commitment towards quality.

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Daewoong and Chime Biologics Partner for Biosimilar Push

Chime Biologics and Daewoong Pharmaceutical have entered into a...

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has...

Aragen Achieves Daretabart Commercial-scale GMP Production

Aragen, a global leader in Contract Research, Development, and...

CordenPharma Seals AmbioPharm Deal to Expand Global Network

CordenPharma, a global contract development and manufacturing organization specializing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป